Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
5.37
-0.04 (-0.83%)
Apr 21, 2026, 9:41 AM EDT - Market open
Compass Therapeutics Employees
Compass Therapeutics had 39 employees as of December 31, 2025. The number of employees increased by 4 or 11.43% compared to the previous year.
Employees
39
Change (1Y)
4
Growth (1Y)
11.43%
Revenue / Employee
n/a
Profits / Employee
-$1,704,846
Market Cap
967.07M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 39 | 4 | 11.43% |
| Dec 31, 2024 | 35 | 3 | 9.38% |
| Dec 31, 2023 | 32 | 6 | 23.08% |
| Dec 31, 2022 | 26 | 2 | 8.33% |
| Dec 31, 2021 | 24 | -7 | -22.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,300 |
| Maravai LifeSciences Holdings | 435 |
| MeiraGTx Holdings | 403 |
| Xencor | 260 |
| Geron | 258 |
| Omeros | 175 |
| Janux Therapeutics | 109 |
| Annexon | 96 |
CMPX News
- 6 weeks ago - Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Compass Therapeutics Provides Corporate Update - GlobeNewsWire
- 3 months ago - Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Compass Therapeutics Announces Key Leadership Appointments - GlobeNewsWire
- 4 months ago - Compass Therapeutics to Participate in the J.P. Morgan 2026 Healthcare Conference - GlobeNewsWire
- 5 months ago - Compass Therapeutics to Participate in Upcoming December Investor Events - GlobeNewsWire
- 5 months ago - Compass Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 months ago - Compass Therapeutics Presents Preclinical Data on CTX-10726, a Differentiated PD-1 x VEGF-A Bispecific Antibody, at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting - GlobeNewsWire